Taken altogether, these results suggest that PKCδ likely contributes to the infiltration of GBM cells in vivo through the c-MET/PKCδ/SRC/STAT3/NOTCH2 signaling axis as it does in vitro (Fig. 5E). This evidence concerns the gene MET and glioblastoma.